Algert Global’s Forte Biosciences FBRX Stock Holding History

Algert Global’s Portfolio FBRX Stock Details FBRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-52	Closed	-$213K	–	358
2019 Q1	$213K	Buy	+52	New	+$201K	0.12%	239

Other funds holding FBRX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SAM

Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return

FCMI

Foresite Capital Management III Larkspur, California $37.9M AUM 6.87% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Algert Global's FBRX Position: Q2 2019 in Review

Algert Global sold out of Forte Biosciences (FBRX) in Q2 2019, closing a stake of 52 shares — an estimated $213K sold.

Algert Global first reported a position in FBRX in Q1 2019 and held it in 1 quarter. The position peaked at $213K in Q1 2019. 74 funds tracked by Wall St. Rank hold FBRX as of Q2 2019.

Algert Global reported no remaining Forte Biosciences position as of Q2 2019 after selling out during the quarter.
Algert Global sold 52 Forte Biosciences shares in Q2 2019, an estimated $213K.
Algert Global first reported a position in Forte Biosciences in Q1 2019 and held it in 1 quarter.
Algert Global's Forte Biosciences position peaked at $213K in Q1 2019.
74 funds tracked by Wall St. Rank held Forte Biosciences as of Q2 2019.

Based on Algert Global's 13F filing for Q2 2019, filed 14 Aug 2019.